vs

Side-by-side financial comparison of Cellectis S.A. (CLLS) and TH International Ltd (THCH). Click either name above to swap in a different company.

Cellectis S.A. is the larger business by last-quarter revenue ($9.5M vs $6.6M, roughly 1.4× TH International Ltd). TH International Ltd runs the higher net margin — -41.2% vs -265.9%, a 224.7% gap on every dollar of revenue.

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

TH International Ltd is the exclusive operator of the Tim Hortons coffee brand in mainland China. It offers freshly brewed coffee, artisanal baked goods, light meals and branded peripheral products, operating physical offline stores and third-party delivery channels, targeting young urban consumers across tier 1, tier 2 and tier 3 cities in China.

CLLS vs THCH — Head-to-Head

Bigger by revenue
CLLS
CLLS
1.4× larger
CLLS
$9.5M
$6.6M
THCH
Higher net margin
THCH
THCH
224.7% more per $
THCH
-41.2%
-265.9%
CLLS

Income Statement — Q2 FY2024 vs Q1 FY2024

Metric
CLLS
CLLS
THCH
THCH
Revenue
$9.5M
$6.6M
Net Profit
$-25.3M
$-2.7M
Gross Margin
Operating Margin
-181.1%
-37.3%
Net Margin
-265.9%
-41.2%
Revenue YoY
375.0%
Net Profit YoY
-51.9%
EPS (diluted)
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLLS
CLLS
THCH
THCH
Q2 24
$9.5M
Q1 24
$6.6M
Q3 23
$1.6M
Q2 23
$2.0M
Q2 22
$2.7M
Net Profit
CLLS
CLLS
THCH
THCH
Q2 24
$-25.3M
Q1 24
$-2.7M
Q3 23
$-17.5M
Q2 23
$-16.6M
Q2 22
$-19.5M
Gross Margin
CLLS
CLLS
THCH
THCH
Q2 24
Q1 24
Q3 23
Q2 23
97.3%
Q2 22
87.9%
Operating Margin
CLLS
CLLS
THCH
THCH
Q2 24
-181.1%
Q1 24
-37.3%
Q3 23
-1258.1%
Q2 23
-1180.5%
Q2 22
-1003.0%
Net Margin
CLLS
CLLS
THCH
THCH
Q2 24
-265.9%
Q1 24
-41.2%
Q3 23
-1064.1%
Q2 23
-831.6%
Q2 22
-714.4%
EPS (diluted)
CLLS
CLLS
THCH
THCH
Q2 24
$-0.28
Q1 24
Q3 23
$-0.31
Q2 23
$-0.20
Q2 22
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLLS
CLLS
THCH
THCH
Cash + ST InvestmentsLiquidity on hand
$149.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$148.6M
Total Assets
$407.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLLS
CLLS
THCH
THCH
Q2 24
$149.0M
Q1 24
Q3 23
Q2 23
$84.4M
Q2 22
$129.4M
Stockholders' Equity
CLLS
CLLS
THCH
THCH
Q2 24
$148.6M
Q1 24
Q3 23
$76.1M
Q2 23
$96.6M
Q2 22
$180.5M
Total Assets
CLLS
CLLS
THCH
THCH
Q2 24
$407.1M
Q1 24
Q3 23
$209.7M
Q2 23
$227.7M
Q2 22
$320.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLLS
CLLS
THCH
THCH
Operating Cash FlowLast quarter
$28.9M
$-511
Free Cash FlowOCF − Capex
$27.6M
FCF MarginFCF / Revenue
290.5%
Capex IntensityCapex / Revenue
13.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLLS
CLLS
THCH
THCH
Q2 24
$28.9M
Q1 24
$-511
Q3 23
Q2 23
$-47.4M
Q2 22
$-60.2M
Free Cash Flow
CLLS
CLLS
THCH
THCH
Q2 24
$27.6M
Q1 24
Q3 23
Q2 23
$-47.9M
Q2 22
$-61.7M
FCF Margin
CLLS
CLLS
THCH
THCH
Q2 24
290.5%
Q1 24
Q3 23
Q2 23
-2391.4%
Q2 22
-2266.7%
Capex Intensity
CLLS
CLLS
THCH
THCH
Q2 24
13.2%
Q1 24
Q3 23
Q2 23
24.1%
Q2 22
56.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons